ArticleLeukemia2013
NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes.
D M Murphy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papertrialcites it